Cargando…
Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease
CONTEXT: Mechanisms underlying pituitary corticotroph adenoma adrenocorticotropin (ACTH) production are poorly understood, yet circulating ACTH levels closely correlate with adenoma phenotype and clinical outcomes. OBJECTIVE: We characterized the 5′ ends of proopiomelanocortin (POMC) gene transcript...
Autores principales: | Araki, Takako, Tone, Yukiko, Yamamoto, Masaaki, Kameda, Hiraku, Ben-Shlomo, Anat, Yamada, Shozo, Takeshita, Akira, Yamamoto, Masato, Kawakami, Yasuhiko, Tone, Masahide, Melmed, Shlomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372657/ https://www.ncbi.nlm.nih.gov/pubmed/34061962 http://dx.doi.org/10.1210/clinem/dgab387 |
Ejemplares similares
-
EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis
por: Araki, Takako, et al.
Publicado: (2017) -
Is GH Replacement for Adult GH Deficiency Safe?
por: Melmed, Shlomo
Publicado: (2022) -
Obesity and Hyperphagia With Increased Defective ACTH: A Novel POMC Variant
por: van der Valk, Eline S, et al.
Publicado: (2022) -
Cushing Mortality in Remission: Not Out of the Woods
por: Kelsall, Alan, et al.
Publicado: (2022) -
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease
por: Gadelha, Mônica, et al.
Publicado: (2022)